Rapport Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $7.73-$42.26 |
Market Cap | $1.3B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.86 |
News
See moreYahoo Finance • 10 days ago
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
Yahoo Finance • 3 months ago
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?
Yahoo Finance • 3 months ago
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
About
CEO | Mr. Abraham N. Ceesay M.B.A. |
Address | 99 High Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 84 |
